Patent US4642309A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4642309A Expired / Lapsed US ⏱️ 0.0 years remaining

Indolin-2-one derivatives preparation thereof and intermediates for the preparation thereof

Assignee: Roche Diagnostics GmbH
•
Filing: 1985-09-26
•
Granted: 1987-02-10
•
Expires: 2005-09-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention provides indolin-2-one derivatives of the general formula: <IMAGE> (I) wherein R1 is a C1-C6 alkyl radical or a radical of the general formula: <IMAGE> in which A is a straight-chained or branched C2-C4 alkylene radical and Z is an oxygen or sulphur atom, R2 and R3, which can be the same or different, are hydrogen or halogen atoms, hydroxyl groups, C2-C6 alkanoyl radicals, C2-C4 alkenyl radicals, C2-C4 alkynyl radicals, C1-C6 alkyl radicals, C1-C6 alkoxy radicals, C2-C4 alkenyloxy radicals, C2-C4 alkynyloxy radicals, C1-C6 alkylthio radicals, C2-C6 alkanoylamido radicals or radicals of the general formula: <IMAGE> in which R4 and R5, which can be the same or different, are hydrogen atoms, C1-C6 alkyl radicals or C3-C10 cycloalkyl radicals or R4 and R5 together represent a C2-C8 alkylene radical optionally interrupted by an oxygen or sulphur atom or by an >N-R6 group, in which R6 is a hydrogen atom or a C1-C6 alkyl radical, X is a hydrogen atom, Y is a hydrogen atom or a group of the general formula <IMAGE> in which Q is a hydrogen atom or, together with X, can also represent a bond and R7 is a heterocyclic radical which is optionally substituted one or more times by hydroxyl or C1-C6 alkyl or is a phenyl radical which is optionally substituted one or more times by halogen, hydroxyl, mercapto, carboxyl, C1-C6 alkoxycarbonyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkylsulphinyl, C114 C6 alkylsulphonyl, C2-C6 alkanoylamido, C1-C6 alkylsulphonylamido, methylenedioxy, nitro, cyano or amino, with the proviso that R1 cannot be a C1-C6 alkyl radical when X and Y are both hydrogen atoms; as well as the pharmacologically acceptable salts thereof. The present invention also provides intermediates of the general formula: <IMAGE> (V) in which R7 is a heterocyclic radical which is optionally substituted one or more times by hydroxy or C1-C6 alkyl or is a phenyl radical which is optionally substituted one or more times by hydroxyl, halogen, mercapto, carboxyl, C1-C6 alkoxycarbonyl, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkylthio, C114 C6 alkylsulphinyl, cyano C1-C6 alkylsulphonyl, C2-C6 alkanoylamido, C1-C6 alkylsulphonylamido, nitro amino or methylenedioxy. Furthermore, the invention provides processes for the preparation of the above indolin-2-one derivatives and the above intermediates, as well as pharmaceutical compositions containing the above indolin-2-one derivatives.

Inventors

  • 👤 Helmut Michel
  • 👤 Klaus Marzenell
  • 👤 Wolfgang Kampe
  • 👤 Wolfgang Bartsch
  • 👤 Wolfgang Schaumann

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 23:12
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/06; A; A61; A61P; A61P25/00; A61P25/02; A61P9/00; A61P9/08; C07D209/00; C07D209/02; C07D209/04; C07D209/30; C07D209/32; C07D209/34; C07D403/00; C07D403/02; C07D403/06; C07D405/00; C07D405/02; C07D405/12; C07D405/14; C07D409/00; C07D409/02; C07D409/06

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 172 words
An indolin-2-one compound of the formula I as follows: ##STR14## wherein R 1 is a C 1 -C 6 alkyl, or a group of the formula ##STR15## wherein A is a straight-chained or branched C 2 -C 4 alkylene and z is oxygen, R 2 is hydrogen, hydroxyl, C 1 -C 6 alkoxy or C 2 -C 4 alkenyloxy, R 3 is hydrogen X is hydrogen Y is hydrogen, or a group of the general formula ##STR16## wherein Q is hydrogen or Q and X together represent a bond, and R 7 is imidazole, triazole, pyrrole, pyrazole, pyridine, thiophene, indole, indazole, or uracil or R 7 is phenyl which is optionally substituted one or two times by hydroxyl, carboxyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulphinyl, C 1 -C 6 alkylsulphonylamido, methylenedioxy, nitro, or amino, with the proviso that R 1 cannot be a C 1 -C 6 alkyl radical when X and Y are both hydrogen atoms; or the pharmacologically acceptable salts thereof.
Claim 2
Dependent Claim 172 words
An indolin-2-one compound of the formula I as follows: ##STR14## wherein R 1 is a C 1 -C 6 alkyl, or a group of the formula ##STR15## wherein A is a straight-chained or branched C 2 -C 4 alkylene and z is oxygen, R 2 is hydrogen, hydroxyl, C 1 -C 6 alkoxy or C 2 -C 4 alkenyloxy, R 3 is hydrogen X is hydrogen Y is hydrogen, or a group of the general formula ##STR16## wherein Q is hydrogen or Q and X together represent a bond, and R 7 is imidazole, triazole, pyrrole, pyrazole, pyridine, thiophene, indole, indazole, or uracil or R 7 is phenyl which is optionally substituted one or two times by hydroxyl, carboxyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulphinyl, C 1 -C 6 alkylsulphonylamido, methylenedioxy, nitro, or amino, with the proviso that R 1 cannot be a C 1 -C 6 alkyl radical when X and Y are both hydrogen atoms; or the pharmacologically acceptable salts thereof.
Claim 3
Dependent Claim 24 words
The compound of claim 1, wherein R 1 is a C 1 -C 6 alkyl radical and X and Q together represent a bond.
Claim 4
Dependent Claim 54 words
The compound of claim 1 wherein Q and X together represent a bond and R 7 is phenyl substituted one or two times by hydroxyl, carboxyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulphinyl, C 2 -C 6 alkanoylamido, C 1 -C 6 alkylsulphonylamido, nitro or amino.
Claim 5
Dependent Claim 39 words
The compound of claim 1, wherein R 1 is the group of the general formula ##STR17## wherein A is ethylene, Z is oxygen, R 2 is hydrogen, hydroxyl, C 1 -C 6 alkoxy or C 2 -C 4 alkenyloxy.
Claim 6
Dependent Claim 10 words
The compound of claim 4 wherein R 2 is hydroxyl.
Claim 7
Dependent Claim 10 words
The compound of claim 4 wherein R 2 is hydrogen.
Claim 8
Dependent Claim 9 words
The compound as claimed in claim 1 designated 4-(2-hydroxy-3-isopropylaminopropoxy)-3-(2-hydroxybenzylidene)-indolin-2-one.
Claim 9
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-(2-hydroxy-3-isopropylaminopropoxy)-3-(2-hydroxy-4-methylthiobenzylidene)-indolin-2-one and the pharmacologically acceptable salts thereof.
Claim 10
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-{2-hydroxy-3-[2-(4-hydroxyphenoxy)ethylamino]-propoxy}-3-(2-hydroxybenzylidene)-indolin-2-one and the pharmacologically acceptable salts thereof.
Claim 11
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-{2-hydroxy-3-[2-(4-hydroxyphenoxy)ethylamino]-propoxy}-3-(2-carboxybenzylidene)-indolin-2-one and the pharmacologically acceptable salts thereof.
Claim 12
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-[2-hydroxy-3-(2-phenoxyethylamino)propoxy]-3-(pyrazol-5-yl)-methyleneindolin-2-one and the pharmacologically acceptable salts thereof.
Claim 13
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-{2-hydroxy-3-[2-(4-hydroxyphenoxy)ethylamino]-propoxy}-3-(2-hydroxybenzyl)-indolin-2-one and the pharmacologically acceptable salts thereof.
Claim 14
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-{2-hydroxy-3-[2-(4-hydroxyphenoxy)ethylamino]-propoxy}-3-(pyrazol-5-yl-methyl)-indolin-2-one and the pharmacologically acceptable salts thereof.
Claim 15
Dependent Claim 15 words
The compound as claimed in claim 1 designated 4-[2-hydroxy-3-(2-phenoxyethylamino)propoxy]-3-(pyrazol-5-yl-methyl)indolin-2-one and the pharmacologically acceptable salts thereof.
Claim 16
Dependent Claim 29 words
A pharmaceutical composition for the treatment of circulatory and cardiac diseases comprising a pharmaceutically acceptable carrier and in effective amounts, an indolin-2-one derivative compound as claimed in claim 1.
Claim 17
Dependent Claim 30 words
A method of treating a subject for circulatory and cardiac diseases which comprises administering to such subject an effective amount of an indolin-2-one derivative compound as claimed in claim 1.
Claim 18
Dependent Claim 12 words
The method as claimed in claim 13 wherein said disease is hypertension.
Claim 19
Dependent Claim 13 words
The method as claimed in claim 13 wherein said disease is angina pectoris.
Claim 20
Dependent Claim 9 words
The compound as claimed in claim 1 designated 4-[2-hydroxy-3-(2-phenoxyethylamino)-propoxy]-indolin-2-one.
Claim 21
Dependent Claim 13 words
The compound of claim 4 wherein X=Y=hydrogen R 2 is hydrogen or hydroxy.
Claim 22
Dependent Claim 79 words
The compound of claim 1 wherein Y is a group of the general formula ##STR18## wherein Q is hydrogen or Q and X together represent a bond, and R 7 is imidazole, triazole, pyrrole, pyrazole, pyridine, thiophene, indole, indazole, or uracil or R 7 is phenyl or phenyl substituted one or two times by hydroxyl, carboxyl, C 1 -C 6 alkoxy, C 1 -C 6 alkylthio, C 1 -C 6 alkylsulphinyl, C 1 -C 6 alkylsulphonylamido, nitro, or amino.

References Cited (Backward Citations)

US3825558A Cited
US3965095A Cited
US3882143A Cited
US4070470A Cited
US4080463A Cited
US4235919A Cited
US4346093A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-02-09 1990-08-11 1991-02-10 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-02-09 1994-08-11 1995-02-10 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-02-09 1998-08-11 1999-02-10 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag